RION LLC is a clinical-stage regenerative medicine company based in Rochester, MN. Established in 2017, RION is revolutionizing regenerative medicine by leveraging the remarkable properties of exosomes, nanoscale extracellular vesicles that act as carriers of biological messages. Through their proprietary platform, RION has isolated a unique exosome phenotype called Platelet Exosome Product (PEP) from platelets, which plays a key role in tissue regeneration in the body. With a commitment to transforming the approach to regenerative medicine, RION is advancing the understanding of PEP's mode of action, scaling exosome manufacturing, and exploring therapeutic applications.
RION's breakthrough manufacturing process allows for the mass production of PEP, addressing the industry challenge of scalability. This innovative Drug Substance contains trillions of platelet-derived regenerative exosomes, making it a superior choice for therapeutic applications. By harnessing the natural regenerative properties of platelets, RION is paving the way for a new era in regenerative medicine, offering the potential for extensive therapeutic application and commercial viability of exosome-based treatments.
Generated from the website